Multicomponent hydrogels for the formation of vascularized bone-like constructs in vitro.


Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
06 2020
Historique:
received: 14 12 2019
revised: 13 03 2020
accepted: 18 03 2020
pubmed: 21 4 2020
medline: 16 4 2021
entrez: 21 4 2020
Statut: ppublish

Résumé

The native extracellular matrix (ECM) is a complex gel-like system with a broad range of structural features and biomolecular signals. Hydrogel platforms that can recapitulate the complexity and signaling properties of this ECM would have enormous impact in fields ranging from tissue engineering to drug discovery. Here, we report on the design, synthesis, and proof-of-concept validation of a microporous and nanofibrous hydrogel exhibiting multiple bioactive epitopes designed to recreate key features of the bone ECM. The material platform integrates self-assembly with orthogonal enzymatic cross-linking to create a supramolecular environment comprising hyaluronic acid modified with tyramine (HA-Tyr) and peptides amphiphiles (PAs) designed to promote cell adhesion (RGDS-PA), osteogenesis (Osteo-PA), and angiogenesis (Angio-PA). Through individual and co-cultures of human adipose derived mesenchymal stem cells (hAMSCs) and human umbilical vascular endothelial cells (HUVECs), we confirmed the capacity of the HA-Tyr/RGDS-PA/Osteo-PA/Angio-PA hydrogel to promote cell adhesion as well as osteogenic and angiogenic differentiation in both 2D and 3D setups. Furthermore, using immunofluorescent staining and reverse transcription-quantitative polymerase chain reaction (RT-qPCR), we demonstrated co-differentiation and organization of hAMSCs and HUVECs into 3D aggregates resembling vascularized bone-like constructs. STATEMENT OF SIGNIFICANCE: This body of work presents a new approach to develop more complex, yet functional, in vitro environments for cell culture while enabling a high level of control, tuneability, and reproducibility. The multicomponent self-assembling bioactive 2D and 3D hydrogels with nanofibrous architecture designed to recreate key molecular and macromolecular features of the native bone ECM and promote both osteogenesis and angiogenesis. The materials induce endothelial cells towards large vascular lumens and MSCs into bone cells on/within the same platform and form vascularized-bone like construct in vitro. This strategy looks encouraging for lifelike bone tissue engineering in vitro and bone tissue regeneration in vivo.

Identifiants

pubmed: 32311533
pii: S1742-7061(20)30166-5
doi: 10.1016/j.actbio.2020.03.025
pii:
doi:

Substances chimiques

Hydrogels 0
Peptides 0
Hyaluronic Acid 9004-61-9
Tyramine X8ZC7V0OX3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

82-94

Subventions

Organisme : Medical Research Council
ID : MR/R015651/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Burak Derkus (B)

Institute of Bioengineering, Queen Mary University of London, E1 4NS London, UK; School of Engineering and Materials Science, Queen Mary University of London, E1 4NS London, UK; Biomedical Engineering Department, Faculty of Engineering, Eskisehir Osmangazi University, 26480 Eskisehir, Turkey; Department of Chemistry, Faculty of Science, Ankara University, 06560 Ankara, Turkey.

Babatunde O Okesola (BO)

Institute of Bioengineering, Queen Mary University of London, E1 4NS London, UK; School of Engineering and Materials Science, Queen Mary University of London, E1 4NS London, UK.

David W Barrett (DW)

Institute of Bioengineering, Queen Mary University of London, E1 4NS London, UK; School of Engineering and Materials Science, Queen Mary University of London, E1 4NS London, UK.

Matteo D'Este (M)

AO Research Institute Davos, Clavadelerstrasse 8, Davos Platz 7270, Switzerland.

Tina T Chowdhury (TT)

Institute of Bioengineering, Queen Mary University of London, E1 4NS London, UK; School of Engineering and Materials Science, Queen Mary University of London, E1 4NS London, UK.

David Eglin (D)

AO Research Institute Davos, Clavadelerstrasse 8, Davos Platz 7270, Switzerland.

Alvaro Mata (A)

Institute of Bioengineering, Queen Mary University of London, E1 4NS London, UK; School of Engineering and Materials Science, Queen Mary University of London, E1 4NS London, UK; School of Pharmacy, University of Nottingham, NG7 2RD Nottingham, UK; Department of Chemical and Environmental Engineering, University of Nottingham, NG7 2RD Nottingham, UK; Biodiscovery Institute, University of Nottingham, NG7 2RD Nottingham, UK. Electronic address: a.mata@nottingham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH